Experimental Imaging Center, IRCCS San Raffaele Scientific Institute, Via Olgettina 60, 20132, Milan, Italy.
School of Medicine, Vita-Salute San Raffaele University, Via Olgettina 58, 20132, Milan, Italy.
Int J Cardiovasc Imaging. 2021 Jan;37(1):291-303. doi: 10.1007/s10554-020-01964-9. Epub 2020 Aug 28.
Coronary sinus (CS) Reducer implantation improves myocardial perfusion and symptoms in patients with debilitating refractory angina. Its impact on myocardial remodeling remain uncertain. Aim of the present study was to assess possible impact of CS Reducer on myocardial systolic-diastolic deformation and microstructural remodeling, as assessed through cardiac magnetic resonance (CMR) feature tracking and mapping analysis. Twenty-eight consecutive patients with refractory angina underwent multiparametric stress CMR before and 4 months after CS Reducer implantation. Eight patients were excluded (6 for absence of inducible ischemia, 2 for artifacts). Modifications in 3D systo-diastolic myocardial deformation were evaluated using feature tracking analysis on rest cine images. Myocardial microstructural remodeling was assessed by native T1 mapping, cellular and matrix volume and extracellular volume fraction (ECV). Collaterally, the percentage of ischemic myocardium (ischemic burden %) and the myocardial perfusion reserve index (MPRI) were measured. After CS Reducer implantation, myocardial contractility improved (ejection fraction rose from 61 to 67%; p = 0.0079), along with longitudinal (from - 16 to - 19%; p = 0.0192) and circumferential strain (from - 18 to - 21%; p = 0.0017). Peak diastolic radial, circumferential and longitudinal strain rate did not change (p > 0.05), and no changes in native T1, ECV, cellular and matrix volume were observed. Myocardial perfusion improved, with a reduction of ischemic burden (13-11%; p = 0.0135), and recovery of intramural perfusion balance in segments with baseline ischemia (MPRi endocardial/epicardial ratio from 0.67 to 0.96; p = 0.0107). CS Reducer improves myocardial longitudinal and circumferential strain, without microstructural remodeling and no impact on diastolic proprieties.
冠状窦(CS)减容术可改善衰弱性难治性心绞痛患者的心肌灌注和症状。但其对心肌重构的影响尚不确定。本研究旨在通过心脏磁共振(CMR)特征跟踪和映射分析评估 CS 减容术对心肌收缩-舒张变形和微观结构重构的可能影响。28 例难治性心绞痛患者在 CS 减容术植入前和植入后 4 个月进行多参数应激 CMR 检查。排除 8 例患者(6 例为无诱发性缺血,2 例为伪影)。使用静息电影图像上的特征跟踪分析评估 3D 收缩-舒张期心肌变形的变化。通过原生 T1 映射、细胞和基质体积以及细胞外容积分数(ECV)评估心肌微观结构重构。此外,还测量了缺血心肌的百分比(缺血负担百分比[IB%])和心肌血流储备指数(MPRI)。CS 减容术植入后,心肌收缩力改善(射血分数从 61%增加到 67%;p=0.0079),同时纵向(从-16%增加到-19%;p=0.0192)和环向应变(从-18%增加到-21%;p=0.0017)也增加。峰值舒张径向、环向和纵向应变率没有变化(p>0.05),且原生 T1、ECV、细胞和基质体积无变化。心肌灌注改善,缺血负担减少(13%-11%;p=0.0135),并且基线缺血节段的腔内灌注平衡恢复(MPRi 心内膜/心外膜比值从 0.67 增加到 0.96;p=0.0107)。CS 减容术可改善心肌的纵向和环向应变,而不会引起微观结构重构,也不会影响舒张特性。